Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
biotechnology
Mountain Valley MD Holdings (MVMD.C) filed a cancer patent and is moving forward with preclinical trials with third party cancer research organizations (CROs) in triple-negative breast cancer, metastatic melanoma…
Revive Therapeutics (RVV.C) signed a research agreement with the University of California, San Francisco (UCSF) to explore Bucillamine as a potential treatment for severe cases of COVID-19 today, according…
Telo Genomics (TELO.V) has co-written and published an academic study regarding their ability to positively identify high-risk versus low-risk smouldering myeloma patients in a longitudinal multiple myeloma clinical study…
Core One Labs (COOL.C) subsidiary, Vocan Biotechnologies, and the University of British Columbia (UBC), came to terms on a collaborative research agreement today, according to a press release. The…
Sixth Wave Innovations (SIXW.C) extended their research and development relationships with the University of Alberta (UofA) and the Li Ka Shing Institute of Virology (LKS) regarding their Accelerated Molecular…
Sixth Wave Innovations (SIXW.C) fired up its fund raising engines on Friday, looking to trade units for CAD$6 million, according to a press release. The company is planning to…
Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of Adelia. There are a…
Mydecine Innovations Group (MYCO.C) expanded their relationship with Applied Pharmaceutical Innovation (API) to include the University of Alberta in support of multiple drug development and clinical trials, according to…
Sixth Wave Innovations (SIXW.C) research team finished the first molecular imprint of the SARS-CoV-2 virus using its AMIPs process and technology today, according to a press release. The AMIPS…